slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 751-780
Pages 3,950
Rows per page 30
Component
751-780 of 118,471
07
The slide lists names, titles, and previous company affiliations for both the Board and Management Team.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 8 hits
03
argenx SE | Results Presentation Deck | 19 slidesargenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · Attention8 hits
33
AstraZeneca | Investor Day Presentation Deck | 42 slidesAstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations 8 hits
04
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 8 hits
03
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention8 hits
03
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention8 hits
38
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Action8 hits
100
Auto Trader Group | Investor Day Presentation Deck | 100 slidesAuto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Beat · Action8 hits
25
Bausch Health Companies | Investor Conference Presentation Deck | 25 slidesBausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction8 hits
27
Standard financial disclosure slide defining non-GAAP metrics and their rationale.Broadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Appendix8 hits
09
This slide outlines regulatory requirements for clinical trial design, including placebo run-in periods, patient population definition, PRO instruments, and primary endpoints.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction8 hits
03
This is the final page of a shareholder letter, including signatures and contact information.Southwest Airlines (LUV) · John Pike and Bobby Xu
Shareholder letter Activist investor Beat · ActionLoop · Cost Of Inaction8 hits
08
The slide uses a four-column layout to categorize strategic product initiatives.Etsy | Investor Presentation Deck | 29 slides · Etsy
Pitch deck Investor relations Beat · What Could BeLoop · Aha Moment8 hits
40
Page 40 of a regulatory filing (likely a Schedule 13D/A).Huntsman Corporation (HUN) · Jeffrey C. Smith
Regulatory filing Activist investor 8 hits
09
The content appears to be a transcript from a video or interview session.Herbalife, Ltd. (HLF) · 01_Pershing_Square
Other Activist investor Beat · Future Vision (Gain)Loop · Confession8 hits
24
This is a page from a research note by Greenlight Capital regarding Allied Capital.Allied Capital (ALD) · David Einhorn
Research note Activist investor 8 hits
41
The slide discusses legal exposure under French civil, criminal, and consumer codes.Accor SA (AC) · Grizzly Research
Research note Short seller Beat · Return with Elixir8 hits
02
Grove | Investor Presentation Deck | 41 slidesGrove | Investor Presentation Deck | 41 slides · Grove Collaborative
Deck Investor relations 8 hits
25
Heartland Financial USA | Results Presentation Deck | 34 slidesHeartland Financial USA | Results Presentation Deck | 34 slides · HTLF
Conference presentation Investor relations Beat · Action8 hits
26
Heartland Financial USA | Results Presentation Deck | 35 slidesHeartland Financial USA | Results Presentation Deck | 35 slides · Heartland Financial USA
Conference presentation Investor relations 8 hits
44
Heartland Financial USA | Results Presentation Deck | 53 slidesHeartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Reflection8 hits
04
The slide is a dense text-based executive summary of quarterly performance and operational updates.Hexagon Purus | Results Presentation Deck | 23 slides · Hexagon Purus
Conference presentation Investor relations Beat · NeedLoop · Voice Of Customer8 hits
02
This is a formal letter/document page, not a typical presentation slide.Herbalife, Ltd. (HLF) · David Klafter
Shareholder letter Activist investor Beat · Complication8 hits
13
The slide uses a circular icon-based layout to represent business segments and lists key financial metrics below each.Maersk | Investor Presentation Deck | 14 slides · Maersk
Conference presentation Investor relations Beat · Why now8 hits
04
The slide is structured in three columns of text detailing specific business unit updates (Maersk Line, Maersk Oil, APM Terminals, Maersk Drilling, Maersk Supply Service).Maersk | Results Presentation Deck | 42 slides · Maersk
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction8 hits
14
Shift | SPAC Presentation Deck | 46 slidesShift | SPAC Presentation Deck | 46 slides · Shift
Pitch deck Investment bank Beat · Traction8 hits
02
This is a page from a shareholder letter by TCI Fund Management regarding Wirecard.Wirecard AG (WDI) · Sir Chris Hohn
Shareholder letter Activist investor Beat · Problem & ComplicationLoop · Cost Of Inaction8 hits
46
The slide presents four distinct Q&A scenarios regarding valuation multiples.N/A · 10X EBITDA
Other Short seller 8 hits
63
TPG | Results Presentation Deck | 64 slidesTPG | Results Presentation Deck | 64 slides · TPG
Conference presentation Investor relations Beat · Action8 hits
05
The slide serves as a formal disclosure regarding the methodology and assumptions behind the pro forma financial statements presented in the filing.UBS | Mergers and Acquisitions Presentation Deck | 17 slides · UBS
Regulatory filing Investment bank Beat · Financials8 hits